固定科研人员/Faculty

张军/Jun Zhang

发布时间:2015/7/22 浏览量:5911

张军  授,博士生导师,长江学者,国家高层次人才特殊支持计划领军人才,厦门大学公共卫生学院副院长,分子疫苗学和分子诊断学国家重点实验室副主任,国家传染病诊断试剂与疫苗工程技术研究中心副主任。长期从事疫苗、诊断研究。曾获国家创新争先奖、国家技术发明二等奖、国家科技进步二等奖、中国青年科学家奖、求是杰出科技成就集体奖、新中国成立70周年纪念章等、中国五四青年奖章等。在《新英格兰医学杂志》《柳叶刀》等刊物发表论文100余篇。做为主要负责人之一参与研发的第一个国产宫颈癌疫苗、世界上第一个戊型肝炎疫苗均已获批上市,两次被《新闻联播》报道。

主要学术兼职

中国疫苗行业协会疫苗临床研究分会副主委;中国疫苗行业协会预防接种专委会副主委;中华预防医学会疫苗临床研究专委会常委;中华预防医学会流行病学分会委员、福建省知识产权协会副会长、Frontiers系列杂志( Frontiers in Medicine, Frontiers in Public Health, Frontiers in Microbiology)传染病领域副编辑、《中国人兽共患病杂志》出版委员会副主委、《中华疾病控制杂志》编委。

Professor,

Associate Dean,

School of Public Health,

Deputy Director,

National Institute of Diagnostics and Vaccine Development in infectious disease,

Xiamen University,

Xiamen, Fujian, 361005

P.R.China

Email: zhangj@xmu.edu.cn

Tel: 0086-592-2183111;   Fax: 0086-592-2181258

http://www.researcherid.com/rid/G-4598-2010

https://orcid.org/0000-0002-6601-9180

Professor Jun Zhang’s research interests focus on the virology, immunology and epidemiology of human pathogens. As one of the leading scientists, he is deeply involved in the innovation and translation of hepatitis E vaccine, HPV vaccine, COVID-19 vaccine and many immunologic diagnostic reagents against infectious pathogens. Among them, Hepatitis E vaccine (Hecolin) and HPV 16/18 bivalent vaccine (Cecolin) had been launched in China; the nine-valent HPV vaccine are under Phase III clinical trial. He had published > 100 papers in peer reviewed journals.

EDUCATION

1989-1994                    Shanghai Medical University,        B.A Preventive Medicine

1994?1997           Shanghai Medical University,              M.S Epidemiology

PROFESSIONAL POSITIONS

2011-Date           Professor, Associate Dean, School of Public Health, Xiamen University

2006-Date       Professor, Deputy Director, National Institute of Diagnostics and Vaccine Development in infectious disease, Xiamen University

2002-2006       Associate Professor, School of Life Sciences, Xiamen University

1997-2002       Research assistant, School of Life Sciences, Xiamen University

SELECTIVE PUBLICATIONS

> 100 publications

  1. Jun Zhang*#, Xue-Feng Zhang#, Shou-Jie Huang, et al. Long-Term Efficacy of a Vaccine against Hepatitis E. New Engl J Med, 2015,372(10):914-922

  2. Zhu FC#, Zhang J#, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet, 2010, 376(9744): 895–902.

  3. Zhang TY, …, Zhang J*, et al.. A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice. Gut, 2020, 69(2):343-354.

  4. Qiao YL*, …Zhang J*, Xia NS*. Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: An interim analysis of a randomized clinical trial. J Natl Cancer Inst, 2020, 112(2):145-153..

  5. Wei F, …, Zhang J*, Xia N. Sex differences in the incidence and clearance of anogenital human papillomavirus infection in Liuzhou, China: an observational cohort study. Clin Infect Dis 2020, 70(1): 82-89.

  6. Lou B, …, Zhang J*, Xia NS, Chen Y*. Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset. Eur Respir J. 2020,56(2):2000763. doi: 10.1183/13993003.00763-2020.

  7. Zhao J, …, Zhang J*, Xia N, Zhang Z*. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020 Mar 28:ciaa344.

  8. Ji MF, …, Zhang J*, Cao SM*. Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China. Ann Oncol. 2019, 30(10):1630-1637.

  9. Su Y, Wei F, …, Zhang J*. Prevalence, Concordance, and Transmission of Human Papillomavirus Infection Among Heterosexual Couples in Liuzhou, China: An Observational Perspective Study. J Infect Dis. 2019, 220(6):980-989.

  10. Huang CH, Y…, Zhang J*, Xia NS*. Influence of Mutations in Hepatitis B Virus Surface Protein on Viral Antigenicity and Phenotype in Occult HBV Strains from Blood Donors. J Hepatol. 2012,57(4):720-9.

  11. Zhang J#, Zhang XF#, Zhou C, et al. Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Clin Microbiol Infect 2014; 20: O397–O405.

  12. Huang Y, Guo X, … Zhang J*. Cytomegalovirus Shedding in Healthy Seropositive Female College Students: A 6-Month Longitudinal Study. J Infect Dis. 2018, 217(7):1069-1073.

微信扫一扫
关注国重室公众号